Download PDF
Thromb Haemost 1985; 53(03): 437
DOI: 10.1055/s-0038-1661427
Letter to the Editor
Schattauer GmbH Stuttgart

Does Dipyridamole Have Antithrombotic Potential?

E A Loeliger
Department of Internal Medicine, Leiden University Hospital, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 21 November 1984

Accepted 19 February 1985

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Editorial. Doubts about dipyridamole as an antithrombotic drug. Drug Therapeut Bull 1984; 22: 25-28
    PubMedGoogle Scholar
  • 2 Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement: a preliminary report. N Engl J Med 1968; 279: 576-580
    CrossrefPubMedGoogle Scholar
  • 3 Sullivan JM, Harken DE, Gorlin R. Effect of dipyridamole on the incidence of arterial emboli after cardiac valve replacement. Circulation 1969; 39 suppl (Suppl. 01) 149-153
    PubMedGoogle Scholar
  • 4 Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med 1971; 284: 1391-1394
    CrossrefPubMedGoogle Scholar
  • 5 Broekmans AW, Loeliger EA. Therapeutic control of anticoagulant treatment. Br Med J 1982; 284: 1330-1331
    PubMedGoogle Scholar
  • 6 Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541
    CrossrefPubMedGoogle Scholar
  • 7 Marcus AJ. Aspirin as an antithrombotic medication. N Engl J Med 1983; 309: 1515-1516
    CrossrefPubMedGoogle Scholar
  • 8 Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR, Bardsley WT, Pluth JR, Wallace RB, Puga FJ, Orszulak TA. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 1984; 310: 209-214
    CrossrefPubMedGoogle Scholar
  • 9 Lorenz RL, Weber M, Kotzur J, Theisen K, Schacky CV, Meister W, Reichardt B, Weber PC. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation Lancet 1984; 1: 1261-1264
    PubMedGoogle Scholar
  • 10 Lubsen J. Effect of anti-thrombotic therapy on bypass graft patency: evidence from a non-randomized study. IXth European Congress of Cardiology. Düsseldorf. 1984
    PubMedGoogle Scholar